Our results are of importance for understanding the pathophysiological role of MICAL2 in cancer cell proliferation and highlight that targeting MICAL2 may represent a novel intervention strategy for inhibiting gastric cancer progression. This evidence concerns the gene MICAL2 and gastric cancer.